 MELVILLE, N.Y., Aug. 09, 2021 GLOBE NEWSWIRE -- BioRestorative Therapies, Inc. BioRestorative OTC: BRTX , a life sciences company focused on stem cell-based therapies, today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission for a proposed underwritten public offering of its securities. This offering will be subject to the registration statement on Form S-1 becoming effective and subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed. 